PSA alterado e aumento da prevalência do câncer de próstata em militares das forças armadas / PSA altered and increased of prostate cancer prevalence in military of the armed forces

Authors

  • Marcelo de Vilela Rebouças Brazilian Journals Publicações de Periódicos, São José dos Pinhais, Paraná
  • Alvany Neto Santiago Santana Sousa
  • Bruno Godoi Sant’ Ana
  • Gutembergue Silva Oliveira Júnior
  • Guilherme de Assis Rodrigues
  • Diego Antônio Calixto de Pinto Gomes Mello

DOI:

https://doi.org/10.34117/bjdv5n11-015

Keywords:

Prostate câncer, Prostate Specific Antigen, Rectal examination, Prostate Biopsy, Prostatic Hyperplasia.

Abstract

Prostate cancer (PCa) is the second type of  most common cancer in men, with a constant increase incidence in Brazil and in the world. In relation to their screening there is a literary divergence as to their need, by the risk of possible complications of subjecting patients to biopsies that diagnose cancers of low agressiveness and that, theoretically, do not require treatment. On the other hand, altered levels of Prostate Specific Antingen (PSA) are found in 85% of men with PCa and the sensitivity of this examnination, combined with the rectal examination, is 95% for diagnosis. The present study aims to identify the relation of altered PSA and the  prevalence increase of PCa in patients of brazilia air force. The methodology consists of a quantitative, restrospective, observational and epidemiological study, performed through 76 medical records between the years of 2016 to 2018, crossing PSA values wtih result of prostate biopsy and rectal examination. Regarding the results, 12% of the analyzed medical records had PSA altered and 55% of these patients had rectal examination discribed as unfavorable (prostatic changes suggestive of malignancy). Furthermore, to pacients with rectal examination unfavorable, 40% had malignancy signs confirmed in prostate biopses. Therefore, it was demonstrated in this study that high levels of PSA has a profound relation with te increase of PCa prevalence, and  when the PSA dosage is associated to rectal examination the relation is more trustworthy.

 

 

References

DINI, L. I.; KOFF, W. J. Perfil do câncer de próstata no Hospital de Clínicas de Porto Alegre. Revista da Associação Médica Brasileira, 2006.

ETXEBERRIA, J. et al. Prostate câncer incidence and mortality in Navarre (Spain). In: Anales del sistema sanitario de Navarra. Gobierno de Navarra, 2018. p.9-15.

GOMES, R., et al. Prostate câncer prevention: A review of the literature. Ciência & Saúde Coletiva. v. 13, n.1, p. 235-246, 2008. INCA - Instituto Nacional de Câncer José Alencar Gomes da Silva. Síntese de Resultados e Comentários.2018.

INCA – Instituto Nacional de Câncer José Alencar Gomes da Silva. Coordenação de Prevenção e Vigilância Estimativa 2002: Câncer de Próstata: Consenso / Instituto Nacional de Câncer José Alencar Gomes da Silva – Rio de Janeiro: INCA, 2002.

INCA - Instituto Nacional de Câncer José Alencar Gomes da Silva. Síntese de Resultados e Comentários.2018.Disponível em:

http://www.inca.gov.br/estimativa/2018/sintese-de-resultados-comentarios.asp. Acessado em: Maio de 2018.

NARDI, A.C., et.al. Urologia Brasil. São Paulo: Editora Planmark, 2013.

PEZARO, C.; WOO, H.H.; DAVIS, I.D. Prostate cancer: measuring PSA. Internal medicine journal, v. 44, n. 5, p. 433-440, 2014.

RAMOS, F. P. et al. Câncer de próstata: revisão geral da literatura acerca dos diversos aspectos da doença. Anais do Seminário Científico da FACIG, n. 4, 2019.

SOCIEDADE BRASILIERA DE URULOGIA. Nota Oficial. Disponível em:

http://sbu-sp.org.br/noticias/nota-oficial-2017-rastreamento-do-cancer-de-prostata/. Acessado em: Maio de 2017

ZHOU, C. K., et al. Prostate câncer incidence in 43 populations world wide: ananalysis of time trends overall and by age group. International journal of cancer, v. 138, n. 6, p. 1388-1400, 2016.

Published

2019-11-01

How to Cite

Rebouças, M. de V., Sousa, A. N. S. S., Ana, B. G. S., Júnior, G. S. O., Rodrigues, G. de A., & Mello, D. A. C. de P. G. (2019). PSA alterado e aumento da prevalência do câncer de próstata em militares das forças armadas / PSA altered and increased of prostate cancer prevalence in military of the armed forces. Brazilian Journal of Development, 5(11), 22817–22825. https://doi.org/10.34117/bjdv5n11-015

Issue

Section

Original Papers